Public Comments Sought by the Department of General Affairs of the National Medical Products Administration on the Circular on Matters Concerning Adjusting the Determination of Attributes of Drug-device Combination Products (Draft for Comment)
Public Comments Sought by the Department of General Affairs of the National Medical Products Administration on the Circular on Matters Concerning Adjusting the Determination of Attributes of Drug-device Combination Products (Draft for Comment)
Public Comments Sought by the Department of General Affairs of the National Medical Products Administration on the Circular on Matters Concerning Adjusting the Determination of Attributes of Drug-device Combination Products (Draft for Comment)
April 17, 2019
The National Medical Products Administration ("NMPA" organized to draw up the Circular on Matters Concerning Adjusting the Determination of Attributes of Drug-device Combination Products (Draft for Comment) (Appendix) according to the "Three Determinations" provision of the NMPA's public institutions in order to further regulate the work in determining attributes of drug-device combination products. It is hereby issued for soliciting public opinions.
Please send comments to the NMPA Department of Medical Device Registration by email before May 17, 2019.
Attn.: Huang Lunliang
Email: mdct@nmpa.gov.cn
Tel: 010-88330608
Circular on Matters Concerning Adjusting the Determination of Attributes of Drug-device Combination Products (Draft for Comment)
Relevant matters concerning adjusting the determination of attributes of drug-device combination products are hereby announced as follows according to the "Three Determinations" provision of the NMPA's public institutions in order to further regulate the work in determining attributes of drug-device combination products:
I.
......
April 17, 2019
The National Medical Products Administration ("NMPA" organized to draw up the Circular on Matters Concerning Adjusting the Determination of Attributes of Drug-device Combination Products (Draft for Comment) (Appendix) according to the "Three Determinations" provision of the NMPA's public institutions in order to further regulate the work in determining attributes of drug-device combination products. It is hereby issued for soliciting public opinions.
Please send comments to the NMPA Department of Medical Device Registration by email before May 17, 2019.
Attn.: Huang Lunliang
Email: mdct@nmpa.gov.cn
Tel: 010-88330608
Circular on Matters Concerning Adjusting the Determination of Attributes of Drug-device Combination Products (Draft for Comment)
Relevant matters concerning adjusting the determination of attributes of drug-device combination products are hereby announced as follows according to the "Three Determinations" provision of the NMPA's public institutions in order to further regulate the work in determining attributes of drug-device combination products:
I.
......